Professional Documents
Culture Documents
https://doi.org/10.1186/s40545-020-00256-w
Abstract
The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as
a challenge for many countries globally is how to ensure the efficient and effective procurement of quality medical
supplies. Existing corruption pressures on procurement—everything from undue influence to the outright bribery
of public officials—has been amplified by the pandemic, and thus demands commensurate policy responses. We
argue that transparency and accountability in procurement are essential to preventing the corruption risks that
threaten the health and well-being of populations.
Keywords: Procurement, Transparency, Accountability, Corruption, COVID-19, Health policy
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
Kohler and Wright Journal of Pharmaceutical Policy and Practice (2020) 13:58 Page 2 of 4
governments to ensure equitable access of essential survival rates in COVID-19 patients with respiratory
medicines for their populations, particularly during these complications [13]. Researchers also conducted success-
unprecedented times of the COVID-19 pandemic. ful early clinical trials into a promising vaccine candi-
date, with the latest results demonstrating the vaccine’s
Corruption and procurement ability to induce a strong immune response [14]. Effect-
Even in non-crisis times, reducing the risk of corruption ive procurement of these products, and others, to treat
in public procurement is a challenge. This holds particu- COVID-19 will depend on robust government procure-
larly true for procurement in the health sector, given its ment practices. Past experience illuminates how corrup-
especially lucrative and technically complex nature. If re- tion in pharmaceutical procurement can distort and
sources allocated to pharmaceutical procurement are restrict equitable access to their life-saving properties by
wasted due to corruption and operational deficiencies, not increasing prices, facilitating the distribution of sub-
only the pharmaceutical system is affected; the health sys- standard and falsified medicines, and creating shortages.
tem as a whole loses out on effectiveness and equity. In Corruption risks in procurement are even more pro-
turn, the public may very well lose trust in governments nounced during times of emergency. During disaster re-
to deliver on their commitments such as ensuring access sponse, huge amounts of additional funding are directed
of the population to essential medicines. to rapidly resolve a critical and complex problem, often
Publicly funded essential medicines are highly vulner- through acquiring limited resources under large
able to corruption if there is weak governance in the pro- amounts of pressure. An estimated US$ 16 trillion has
curement system [7]. Savedoff and Grépin, accordingly, already been spent by governments globally on their re-
describe corrupt activities that may take place in the sponses to COVID-19 [15]. The massive amounts of
pharmaceutical procurement processes such as bribes for public funding that are allocated to procurement are not
inspectors; improper bidding procedures for purchasing; to be overlooked. And what is more, existing corruption
diversion of the public drug supply to private practice; pressures on procurement—everything from undue in-
kickbacks for referrals; and pharmacies or drug shops sell- fluence and/or bribery on public officials—are further
ing illegal items [8]. Ware et al. also explain how bribes or amplified by the pandemic. Efforts to rapidly procure ur-
kickbacks are common forms of corruption in public pro- gent goods may require flexibility, speed, and a level of
curement [9]. Corruption in procurement may be individ- discretion that can further widen the risks of corruption.
ual or systemic; in China, Rose-Ackerman and Yan Suppliers may exploit shortages to demand grossly in-
highlight how individuals with procurement responsibil- flated prices. Relaxed checks and balances can result in
ities may engage in corrupt behavior, while the govern- the purchasing of sub-standard or falsified products,
ment at large may play a role by granting promotions to which undermine health security and reduce confidence
physicians willing to make favorable procurement deci- in public institutions [16]. Unscrupulous politicians may
sions for firms with ties to the state [10]. use the disruption to enrich themselves or their friends.
Fraud in hospital procurement is also of particular risk Examples of alleged corruption during the pandemic are
because of the technical expertise required to purchase already bountiful in many countries. In an effort to procure
pharmaceuticals. Spending large sums of money on large N95 face masks, the United States Federal Government
volumes of medicines and medical equipment, hospitals gave a direct award of US$ 55 million to a company that
have been the object of a wide range of corrupt activities, had no experience in supplying medical supplies and no re-
including kickbacks in procurement and the delivery of ex- corded employees [17]. In the UK, the government directly
pired and substandard products [11]. There have also been procured 3.5 million testing kits, which later turned out to
several high-profile cases showing the widespread prolifera- be unusable [18], while a senior procurement official for
tion of kickbacks and bribes from pharmaceutical firms to the National Health Service (NHS) in London was reported
doctors to influence decisions over prescriptions and there- to have traded PPE for private gain [19]. In Brazil, it was re-
fore procurements. For example, this year, Novartis paid ported that the Federal Government purchased masks from
US$ 678 million to settle a fraud lawsuit, which detailed its a supplier with ties to President Jair Bolsonaro that were 67
wide-reaching kickback program, to influence doctors to percent more expensive than the other supplier bids in the
prescribe specific medicines in the United States [12]. same procurement competition [20].
As COVID-19 threatens a global surge in substandard
Corruption in procurement: COVID-19 and falsified products [21], it is even more important to
Promising breakthroughs in COVID-19 medicines re- understand the complex enabling relationship corrup-
search offer seemingly rare glimpses of hope in the fight tion in procurement of medicines has with substandard
against the pandemic. For example, a University of Ox- and falsified medicines. If proper procedures are not in
ford randomized clinical trial demonstrated the benefi- place, drug shortages can provide an opportunity for the
cial use of dexamethasone, a generic drug, in improving proliferation of substandard and falsified medicines [22].
Kohler and Wright Journal of Pharmaceutical Policy and Practice (2020) 13:58 Page 3 of 4
Preventing corruption risks in procurement: The Organization Collaborating Centre for Governance, Accountability, and
role of transparency and accountability Transparency in the Pharmaceutical Sector. Tom Wright is a Senior Research
and Advocacy Officer with anti-corruption NGO Transparency International,
How can we stop the pervasive risks of corruption that where he leads the organization’s efforts to promote open contracting in
threaten the health and well-being of populations? For health procurement.
one, we need to ensure that there is transparency in the
whole of the procurement process. Transparency requires Funding
This paper was partially supported by a Leslie Dan Faculty of Pharmacy,
information on procurement decisions that are publicly University of Toronto Clinical, Social and Administrative (CSAP) Pharmacy
available. This can allow prices paid for the same health grant to Jillian Kohler. This article was supported by funding from the Leslie
products to be compared across a local, regional, or na- Dan Faculty of Pharmacy New Initiative and Innovation Award.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.